ketanserin has been researched along with Arterial Occlusive Diseases in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lüscher, TF | 1 |
| Tanner, FC | 1 |
| Bühler, FR | 1 |
| Hollenberg, NK | 1 |
| De Cree, J | 1 |
| Leempoels, J | 1 |
| Demoen, B | 1 |
| Roels, V | 1 |
| Verhaegen, H | 1 |
| Wiecek, A | 1 |
| Grzeszczak, W | 1 |
3 reviews available for ketanserin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
Topics: Aged; Animals; Arterial Occlusive Diseases; Blood Platelets; Cardiovascular Diseases; Cerebrovascula | 1992 |
Collateral arterial tree and responses to serotonin.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Collateral Circulation; Humans; Ketanserin; S | 1987 |
[Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
Topics: Antihypertensive Agents; Arterial Occlusive Diseases; Blood Pressure; Humans; Hypertension; Ketanser | 1987 |
1 trial available for ketanserin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.
Topics: Aged; Arterial Occlusive Diseases; beta-Thromboglobulin; Cardiovascular Diseases; Double-Blind Metho | 1985 |